< Back to all Breaking News
RTTR
5/7/2019 09:05am
Ritter Pharmaceuticals completes dosing for Phase 3 Liberatus study 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
